US Broker Ratings

Summit Therapeutics Inc. (SMMT) Investor Outlook: Analyzing the 83.45% Potential Upside in Biotech

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a noteworthy contender in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $15.29 billion, this Miami-based biopharmaceutical company..

Verona Pharma (VRNA) Stock Analysis: Exploring a Significant 12% Upside Potential in the Biotech Sector

Verona Pharma plc (NASDAQ: VRNA), a key player in the biotechnology industry, has captured investor attention with its promising prospects in the healthcare sector. Operating out of London, this biopharmaceutical..

Illumina, Inc. (ILMN) Stock Analysis: Exploring a 30% Potential Upside Amidst Challenging Market Conditions

Illumina, Inc. (NASDAQ: ILMN), a leading player in the diagnostics and research sector, stands at a crucial juncture as investors weigh its growth potential against current market challenges. With a..

Globus Medical, Inc. (GMED): Investor Outlook Reveals 42% Upside Potential in the Healthcare Sector

For investors navigating the healthcare sector, Globus Medical, Inc. (NYSE: GMED) presents a compelling opportunity, particularly given its substantial upside potential of 42.13%. As a leading player in the medical..

Quest Diagnostics (DGX) Stock Analysis: Navigating a 5.5% Upside with Strong Revenue Growth

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, continues to capture investor attention. As a leader in the Diagnostics & Research industry, Quest Diagnostics is strategically..

Masimo Corporation (MASI) Stock Analysis: Navigating Growth and Innovation in Healthcare Technology

Masimo Corporation (NASDAQ: MASI), a key player in the healthcare sector specializing in medical devices, has demonstrated impressive strides in innovation and market presence. With a current market capitalization of..

Corcept Therapeutics (CORT) Stock Analysis: Unlocking Potential with Nearly 99% Upside

Investors looking for opportunities in the biotechnology sector should cast their eyes on Corcept Therapeutics Incorporated (CORT). With a market capitalization of $7.38 billion, Corcept operates within the healthcare sector,..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unpacking a 69% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a distinguished player in the biotechnology sector, with its focus on developing life-saving therapies for rare diseases. With a market capitalization of $10.86 billion,..

Waters Corporation (WAT) Stock Analysis: Understanding the 10% Upside in the Healthcare Sector

Waters Corporation (NYSE: WAT) stands as a global leader in the diagnostics and research industry, a pivotal segment of the healthcare sector. With its headquarters in Milford, Massachusetts, and a..

Repligen Corporation (RGEN) Stock Analysis: A Strong Buy with 42.83% Upside Potential

Repligen Corporation (NASDAQ: RGEN) has captured the attention of investors with an impressive potential upside of 42.83% based on current analyst ratings. Operating within the thriving healthcare sector, specifically the..

Ascendis Pharma A/S (ASND) Stock Analysis: A 30% Potential Upside with Solid Buy Ratings

Ascendis Pharma A/S (NASDAQ: ASND), a prominent name in the biotechnology sector, is carving out a robust niche in the healthcare industry. Specializing in developing TransCon-based therapies to address unmet..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 35% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents an intriguing proposition with its diversified portfolio in medical devices and health technology. With a market..

Doximity, Inc. (DOCS) Stock Analysis: Exploring the 5.26% Potential Upside in the Healthcare Sector

Doximity, Inc. (NYSE: DOCS) stands out as a pivotal player in the healthcare sector, specifically within the realm of Health Information Services. With a market capitalization of $11.05 billion, this..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 28.89% Potential Upside for Investors

Merck & Company, Inc. (NYSE: MRK) stands as a formidable entity in the healthcare sector, particularly within the drug manufacturing industry. As a global healthcare leader, Merck’s operations span human..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 75% Revenue Surge in the Healthcare Tech Sector

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, is attracting significant attention from investors following a striking 75.40% revenue growth. With a current market capitalization..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth

For investors seeking opportunities in the biotech sector, Exelixis, Inc. (NASDAQ: EXEL) presents a compelling case with its strong focus on oncology therapies and impressive revenue growth. With a market..

STERIS plc (STE) Stock Analysis: Navigating Growth Potential with a 7.95% Upside

For investors searching for a robust player in the healthcare sector, STERIS plc (NYSE: STE) presents a compelling opportunity. With a market capitalization nearing $24 billion, STERIS stands as a..

Bristol-Myers Squibb (BMY) Stock Analysis: Unveiling a 17.94% Potential Upside and Robust Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY) is a significant player in the healthcare sector, known for its robust portfolio of biopharmaceutical products spanning oncology, hematology, immunology, and more. With a market..

Royalty Pharma plc (RPRX) Stock Analysis: Unlocking a 22.92% Potential Upside in the Biotech Sector

For investors with a keen eye on the biotechnology sector, Royalty Pharma plc (NASDAQ: RPRX) presents an intriguing opportunity. As one of the leading financiers in the biopharmaceutical industry, Royalty..

GSK plc (GSK) Stock Analysis: Evaluating Growth Potential and Dividend Appeal

GSK plc (NYSE: GSK), a prominent player in the healthcare sector, operates within the Drug Manufacturers – General industry. Based in the United Kingdom, GSK holds a significant market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds